Podcasts about Molecular biology

We sat down with Dr. Troy Spurrill to discuss Alpha-Gal, the tick-borne condition making Americans allergic to red meat, and the growing questions surrounding Bill Gates, ticks, and the war on meat. Dr. Spurrill shares what he has seen in his own practice, including whether Alpha-Gal can be reversed, how people can prepare their bodies, and what steps may help prevent tick-related illness before it starts. From Lone Star ticks and immune system health to gut issues, sleep, copper, zinc, and spiritual discernment, this conversation gives viewers a hopeful path forward in the middle of a concerning health trend.TO WATCH ALL FLYOVER CONTENT: www.theflyoverapp.comFollow and Subscribe on YouTube: https://www.youtube.com/@TheFlyoverConservativesShowDr. Troy Spurrill is the founder and CEO of Synapse Center for Health and Healing.  He started Synapse over 26 years ago with a vision to bring an integrative approach to healthcare through functional medicine, making Synapse an internationally known center for true health.He received a Bachelor's of Science in Molecular Biology from the University of Manitoba, and a Doctorate of Chiropractic from Northwestern Health Sciences University.  He has extensive training in Functional Neurology, Nutrition, and Applied Kinesiology. Dr. Troy is an author and international lecturer on wellness and brain based healing.  Dr. Troy SpurrillWEBSITE: www.officialsynapse.com -------------------------------------------

In some of our previous episodes, we've explored the interesting paths that  Wolf Greenfield attorneys have taken as they eventually made their way to IP law. One thing that separates Wolf Greenfield from other firms is the depth of real-world experience many of its attorneys possess. In fact, over half of the professionals at Wolf Greenfield worked in science and technology industries prior to entering law.Kevin MacDonald, a Shareholder in Wolf Greenfield's Biotechnology practice, is an ideal example. After earning a degree in biology at Boston College, Kevin went to England to get his Master's in Molecular Biology and then back to North America for his PhD at McGill University's Institute of Parasitology in Montreal. Before his graduate studies and eventually going to law school, Kevin worked as a Life Science and Healthcare Industry Analyst at the British Consulate-General in Boston.In this episode of IP Talk with Wolf Greenfield,  Kevin discusses his path from the world of science to IP law and his current work assisting clients with IP strategy, portfolio management, and patent prosecution and counseling.Here are a few highlights from the conversation:01:18 - Kevin's background in biology02:33 - How Kevin became interested in parasitology03:10 - Serving as an analyst at the British Consulate-General04:21 - Making the switch to law05:38 - The challenges of transitioning from science to a legal career06:21 - Kevin's current practice at Wolf Greenfield07:20 - Some of the most exciting things happening in biopharma today08:18 - Kevin's efforts as a board member of the British American Business Council of New England###

The final of four interviews with Massapequa's candidates running in Massapequa's school board election on Tuesday May 19th. Dr. Lynn Russo, PhD ESQ is a practicing lawyer with a PHD in Molecular Biology. Russo may be the most educated candidate and discusses her campaign. - Russo addresses a rather offensive campaign flyer that has been distributed featuring disturbing images and accusations about her and fellow candidate Bobby Bonett. - She discusses why she believes "Save The Chief" lawsuits to save Massapequa's Chief mascot will not work. - Why she believes Massapequa should have Universal Pre K. - Massapequa's Transgender bathroom and locker room policy. 

Send us Fan MailFor more than 30 years, small cell lung cancer has remained one of the most aggressive and difficult-to-treat cancers - marked by rapid progression, high relapse rates, and very few meaningful advances. But that may finally be starting to change.Today, we're joined by Dr. Angela Coxon, Ph.D., Vice President of Research and Development at Amgen ( https://www.amgen.com/ ), where she helps lead the development of next-generation therapies aimed at tackling exactly these kinds of challenges. Her work spans discovery research, translational medicine, and molecular oncology - bridging the gap between early scientific insight and real-world impact for patients.If you've been following the show, you may remember our conversation with Amgen's Dr. Ryan Potts, where we explored the emerging concept of Induced Proximity - the idea that instead of simply blocking biology, we can design drugs that bring components together to create entirely new functions. That idea is now playing out in the clinic through approaches like bispecific T-cell engagers, which physically link immune cells to cancer cells and force a targeted immune response - offering a new way to go after tumors that have historically been very hard to treat.Dr. Coxon earned her D. Phil in Molecular Biology from the University of Oxford and completed postdoctoral training in vascular biology at Harvard Medical School and Brigham and Women's Hospital. She has built her career at the intersection of cutting-edge biology and strategic drug development, contributing to Amgen's pipeline in areas of significant unmet need, including lung cancer.#SmallCellLungCancer #SCLC #CancerBreakthrough #Immunotherapy #CancerResearch #Biotech #Amgen #DrugDevelopment #Oncology #CancerTreatment #BiTE #BispecificAntibodies #InducedProximity #PrecisionMedicine #ClinicalTrials #MedicalInnovation #FutureOfMedicine #LungCancerAwareness #TranslationalMedicine #Biology #SciencePodcast #HealthcareInnovation #CancerTherapy #Pharma #NextGenMedicineSupport the show

HIV research is one of the clearest examples of molecular biology in action. In this Mol Bio Minutes episode, Dr. Ryan Jeep walks through how fundamental molecular techniques power everything from detection to drug resistance studies to cure-focused research. Ryan begins with HIV biology and detection, explaining how qRT-PCR enables highly sensitive viral load measurement. These assays not only detection strategies but also support research to monitor treatment efficacy and viral rebound. From there, he moves into drug resistance, describing how sequencing, RT-PCR, and cloning strategies help researchers map resistance-associated mutations. By generating recombinant reporter viruses and measuring infectivity against different drugs, scientists can better understand treatment failure and move toward more personalized therapeutic strategies. Finally, Ryan explores cutting-edge cure research, including CRISPR-Cas9 approaches aimed at either disabling integrated viral genomes or engineering HIV-resistant immune cells. Across all three areas one theme remains constant: PCR, sequencing, and cloning form the technological backbone of HIV research. As these tools continue to evolve, so too does the potential to improve outcomes and one day eliminate the virus entirely. Since recording this episode, Ryan has joined KBI Biopharma as a Scientist l in their Formulation Development Group. Helpful resources and links: Access Stanford University's HIV Drug Resistance Database. Visit International AIDS Society's Towards an HIV Cure site, which includes resources.  Access Thermo Fisher PCR resources and products. Learn about RT-qPCR, which is relevant to HIV research.  Explore the cloning technologies referenced in this episode.  Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Podcast: Bites and Bytes Podcast (LS 26 · TOP 10% what is this?)Episode: Your Food Waste Has a Second Life. Meet Insect Agriculture with Dr. Heather Jordan & Cheryl PreyerPub date: 2026-05-05Get Podcast Transcript →powered by Listen411 - fast audio-to-text and summarizationMost people have never heard of insect agriculture. By the end of this episode, you'll wonder how you missed it.Bites & Bytes Podcast host Kristin King sits down with Dr. Heather Jordan, microbiologist, professor at Mississippi State University, and site director for the NSF-funded Center for Insect Biomanufacturing and Innovation (CIBI), and Cheryl Preyer, the center's industry liaison and former fast food executive, to unpack one of the most quietly consequential shifts happening in the global food system right now.For consumers, this is where your food waste is going next and why that matters for everything from the fish on your plate to the cost of your groceries. Black soldier fly, cricket, and mealworm farming aren't science fiction. They're converting food waste into high-quality livestock feed, fertilizer, and protein at scale. Research is even showing promise in using these insects to remove plastics, antibiotics, and heavy metals from our environment.For professionals in cyber-physical risk, OT security, and food and agriculture cybersecurity, pay attention. Insect agriculture facilities are automated, sensor-dependent production environments with real operational technology vulnerabilities, and this industry is scaling fast with limited security frameworks in place (aka a factory) This is the circular bioeconomy in action. And it already exists.---------------Guest Contact Information:Dr. Heather JordanProfessor of Microbiology and Molecular Biology, Mississippi State University, and Site Director, Center for Insect Biomanufacturing and Innovation (CIBI)Cheryl PreyerIndustry Liaison Officer, Center for Insect Biomanufacturing and InnovationCenter for Insect Biomanufacturing and Innovation ---------------Episode Key Highlights‍ 00:08:01 — "I Traded Fries for Flies" — Cheryl's Origin Line00:11:49 — Insect Farming Is Livestock Farming00:12:37 — "Feed the Food That Feeds Us."00:16:02 — What a Black Soldier Fly Actually Does as an Adult00:23:19 — Why Organic Chickens Need Synthetic Methionine00:23:50 — The Lauric Acid and Coconut Connection00:28:34 — Using Everything But the Oink00:39:51 — The Cricket Densovirus Crisis That Wiped Out Facilities00:50:15 — Heather's West Africa Origin Story---------------

Michael Jewett is a pioneer of cell-free biotechnology. Instead of using living microbes as factories, he uses their internal molecular machinery to make valuable proteins, medicines, diagnostics, and other chemicals. Jewett recently used the technique for vaccine production in an approach that could produce up to 150,000 doses from one liter. He believes cell-free biotech could democratize the production of essential medicines, improve water safety, and help convert atmospheric carbon into useful products, among other promising possibilities. “It's just-add-water biotechnology,” Jewett tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Michael Christopher Jewett Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces Mike Jewett, a professor of bioengineering and chemical engineering at Stanford University. (00:03:23) What Is Cell-Free Biotechnology? Using the internal machinery of cells without the cells themselves. (00:04:20) Removing “Evolutionary Baggage” Why cells' natural priorities can conflict with engineering goals. (00:07:41) Advantages of Cell-Free Systems From large-scale production to decentralized, on-demand manufacturing. (00:11:40) Making Proteins Outside Cells How DNA instructions are used to produce functional proteins. (00:13:49) Biosensors for Water Safety Detecting contaminants like lead using engineered proteins. (00:17:05) Engineering Better Sensors Improving sensitivity and selectivity through protein design. (00:20:33) AI in Bioengineering How data and models accelerate discovery and design. (00:23:22) Sustainability & Carbon Capture Turning atmospheric carbon into useful chemicals. (00:26:18) Building New Biological Pathways Combining chemistry and biology to create novel production systems. (00:27:54) From Molecules to Materials How acetyl-CoA enables fuels, plastics, and other products. (00:30:51) Teaching Biotechnology Making biotech accessible through hands-on, “just-add-water” kits. (00:33:12) Future In a Minute Rapid-fire Q&A: innovation, collaboration, and the future of biotech. (00:35:32) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Two Bees in a Podcast, Amy Vu and Dr. Jamie Ellis are joined by Dr. Leonard Foster, a Professor in Biochemistry and Molecular Biology, Faculty of Medicine, as well as the director of the Life Sciences Institute at the University of British Columbia. They discuss elevated virus infections in honey bee queens and what that means for colonies. Check out our website: www.ufhoneybee.com for additional resources from today's episode. 

In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Leif Larsen, Director of Biology at Vipergen, about the power of DNA-encoded libraries (DELs) in modern drug discovery. DEL technology enables researchers to screen extremely large chemical libraries by attaching a unique DNA barcode to each compound, allowing millions, or even hundreds of millions, of compounds to be analyzed simultaneously through sequencing.  Larsen explains how Vipergen's platform flips traditional screening methods by storing massive compound libraries in a single tube and identifying binding interactions through DNA sequencing. He also describes their proprietary Binder Trap Enrichment (BTE) method, which links DNA barcodes when compounds successfully bind their protein targets. One of the company's most innovative advances is performing DEL screening inside living Xenopus oocytes. By expressing target proteins in these large cells and microinjecting DNA-encoded libraries, researchers can evaluate binding events in a physiologically relevant environment. The discussion also explores how this technology accelerates early drug discovery timelines and enables screening of difficult targets such as transcription factors and membrane proteins. Larsen closes by highlighting emerging areas such as PROTAC-based targeted protein degradation and how DEL screening can help identify molecules suitable for these next-generation therapeutic strategies. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Can liver disease be prevented? Could lifestyle play a major role in reducing the risk and in the treatment if liver disease? What are the major causes of liver diseases? Dr. Ajaz is a highly trained clinician with a deep passion for Lifestyle Medicine. She holds certifications from the British Society of Lifestyle Medicine and the International Board of Lifestyle Medicine. I has the pleasure of speaking to her in her home in London where we talked about all things liver health, disease prevention and treatments.  In this deep dive, we cover:  The prevalence of liver disease What are the major factors that cause liver disease The signs and symptoms of the condition The role of lifestyle medicine in prevention, treatment and management  Dr. Ajaz earned her MPhil in Biochemistry and Molecular Biology, followed by a PhD in Diabetes, Endocrinology, and Metabolism from King's College London in 2016. With over 17 years of experience as both a medical doctor and a researcher in the translational field, she has dedicated her career to investigating non-invasive biomarkers and preventative strategies for early detection of chronic metabolic diseases. https://www.kch.nhs.uk/about/get-involved/groups-and-events/livfit/ https://www.provigilant.co.uk/wellness https://hssh.health/consultants/dr-saima-ajaz/

Imagine a future where we grow houses rather than build them. Where smartphones are alive, clothing has opinions and all human knowledge fits into a speck of DNA. A world where disease is a thing of the past and the human lifespan is dramatically extended.To achieve this, says Adrian Woolfson, founder of the genome writing company Genyro, we must transform biology into a predictive, programmable engineering material. That means decoding the generative grammar of DNA: the language of life itself. We will then be able to author genomes—and, if we choose, even rewrite our own.In On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, 2026), Woolfson describes how we are at the cusp of a technological revolution, driven by the convergence of artificial intelligence and synthetic biology. Currently at the scribbling phase—writing the genomes of viruses, bacteria and yeast—we will eventually author the genomes of extinct and never-before-realized species. Life will become computable, detached from its past and no longer bound by Darwinian evolution.While offering extraordinary opportunities, this power also carries great risk, and it is vital for everyone to understand what the future might hold. In this groundbreaking work, Woolfson provides a guide to this bold new world, offering a moral compass to help us do so safely, wisely and ethically. Adrian Woolfson is the cofounder of Genyro, a California-based biotechnology company specializing in synthetic genome design and construction. He studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. Greg is the Executive Director and Founder of the World War II Discussion Forum (wwiidf.org). He also has a strong interest in literature, culture, religion, science and philosophy (translation: he's an eclectic reader who is constantly missing deadlines for book reviews). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Imagine a future where we grow houses rather than build them. Where smartphones are alive, clothing has opinions and all human knowledge fits into a speck of DNA. A world where disease is a thing of the past and the human lifespan is dramatically extended.To achieve this, says Adrian Woolfson, founder of the genome writing company Genyro, we must transform biology into a predictive, programmable engineering material. That means decoding the generative grammar of DNA: the language of life itself. We will then be able to author genomes—and, if we choose, even rewrite our own.In On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, 2026), Woolfson describes how we are at the cusp of a technological revolution, driven by the convergence of artificial intelligence and synthetic biology. Currently at the scribbling phase—writing the genomes of viruses, bacteria and yeast—we will eventually author the genomes of extinct and never-before-realized species. Life will become computable, detached from its past and no longer bound by Darwinian evolution.While offering extraordinary opportunities, this power also carries great risk, and it is vital for everyone to understand what the future might hold. In this groundbreaking work, Woolfson provides a guide to this bold new world, offering a moral compass to help us do so safely, wisely and ethically. Adrian Woolfson is the cofounder of Genyro, a California-based biotechnology company specializing in synthetic genome design and construction. He studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. Greg is the Executive Director and Founder of the World War II Discussion Forum (wwiidf.org). He also has a strong interest in literature, culture, religion, science and philosophy (translation: he's an eclectic reader who is constantly missing deadlines for book reviews). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

Imagine a future where we grow houses rather than build them. Where smartphones are alive, clothing has opinions and all human knowledge fits into a speck of DNA. A world where disease is a thing of the past and the human lifespan is dramatically extended.To achieve this, says Adrian Woolfson, founder of the genome writing company Genyro, we must transform biology into a predictive, programmable engineering material. That means decoding the generative grammar of DNA: the language of life itself. We will then be able to author genomes—and, if we choose, even rewrite our own.In On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, 2026), Woolfson describes how we are at the cusp of a technological revolution, driven by the convergence of artificial intelligence and synthetic biology. Currently at the scribbling phase—writing the genomes of viruses, bacteria and yeast—we will eventually author the genomes of extinct and never-before-realized species. Life will become computable, detached from its past and no longer bound by Darwinian evolution.While offering extraordinary opportunities, this power also carries great risk, and it is vital for everyone to understand what the future might hold. In this groundbreaking work, Woolfson provides a guide to this bold new world, offering a moral compass to help us do so safely, wisely and ethically. Adrian Woolfson is the cofounder of Genyro, a California-based biotechnology company specializing in synthetic genome design and construction. He studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. Greg is the Executive Director and Founder of the World War II Discussion Forum (wwiidf.org). He also has a strong interest in literature, culture, religion, science and philosophy (translation: he's an eclectic reader who is constantly missing deadlines for book reviews). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

Imagine a future where we grow houses rather than build them. Where smartphones are alive, clothing has opinions and all human knowledge fits into a speck of DNA. A world where disease is a thing of the past and the human lifespan is dramatically extended.To achieve this, says Adrian Woolfson, founder of the genome writing company Genyro, we must transform biology into a predictive, programmable engineering material. That means decoding the generative grammar of DNA: the language of life itself. We will then be able to author genomes—and, if we choose, even rewrite our own.In On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, 2026), Woolfson describes how we are at the cusp of a technological revolution, driven by the convergence of artificial intelligence and synthetic biology. Currently at the scribbling phase—writing the genomes of viruses, bacteria and yeast—we will eventually author the genomes of extinct and never-before-realized species. Life will become computable, detached from its past and no longer bound by Darwinian evolution.While offering extraordinary opportunities, this power also carries great risk, and it is vital for everyone to understand what the future might hold. In this groundbreaking work, Woolfson provides a guide to this bold new world, offering a moral compass to help us do so safely, wisely and ethically. Adrian Woolfson is the cofounder of Genyro, a California-based biotechnology company specializing in synthetic genome design and construction. He studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. Greg is the Executive Director and Founder of the World War II Discussion Forum (wwiidf.org). He also has a strong interest in literature, culture, religion, science and philosophy (translation: he's an eclectic reader who is constantly missing deadlines for book reviews). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/technology

Imagine a future where we grow houses rather than build them. Where smartphones are alive, clothing has opinions and all human knowledge fits into a speck of DNA. A world where disease is a thing of the past and the human lifespan is dramatically extended.To achieve this, says Adrian Woolfson, founder of the genome writing company Genyro, we must transform biology into a predictive, programmable engineering material. That means decoding the generative grammar of DNA: the language of life itself. We will then be able to author genomes—and, if we choose, even rewrite our own.In On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence (MIT Press, 2026), Woolfson describes how we are at the cusp of a technological revolution, driven by the convergence of artificial intelligence and synthetic biology. Currently at the scribbling phase—writing the genomes of viruses, bacteria and yeast—we will eventually author the genomes of extinct and never-before-realized species. Life will become computable, detached from its past and no longer bound by Darwinian evolution.While offering extraordinary opportunities, this power also carries great risk, and it is vital for everyone to understand what the future might hold. In this groundbreaking work, Woolfson provides a guide to this bold new world, offering a moral compass to help us do so safely, wisely and ethically. Adrian Woolfson is the cofounder of Genyro, a California-based biotechnology company specializing in synthetic genome design and construction. He studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. Greg is the Executive Director and Founder of the World War II Discussion Forum (wwiidf.org). He also has a strong interest in literature, culture, religion, science and philosophy (translation: he's an eclectic reader who is constantly missing deadlines for book reviews). Learn more about your ad choices. Visit megaphone.fm/adchoices

What if you could lift, tighten, and rejuvenate your face and body—without Botox, fillers, or toxic chemicals? In this episode, I sit down with Dr. Troy Spurrill and his team to uncover a completely natural, holistic approach to skin health, anti-aging, and total body transformation… and friends, the results are REAL.

In questa puntata Leonardo e Francesca ci parlano di social network e data center orbitali. In apertura, Leonardo ci racconta come social del calibro di X (Twitter) possono influenzare la scelta politica degli elettori tramite la scelta di un feed algoritmico o cronologico.In esterna, passiamo la linea a Valeria che intervista Edoardo Gianni, ricercatore al MRC Laboratory of Molecular Biology di Cambridge per parlarci di RNA auto-replicante che potrebbe essere all'origine della vita sulla Terra. Edoardo ci spiega cosa sono i ribozimi e cos'ha di speciale il ribozima QT45 che ha scoperto e la cui attività è descritta in un recente articolo su Science (https://doi.org/10.1126/science.adt2760).Torniamo in studio con la consueta barza brutta e poi con Francesca, che ci parlerà di data center orbitali, analizzandone le problematiche e cercando di capire insieme la reale fattibilità di questi ambiziosi (e, forse, futuristici) progetti.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/scientificast-la-scienza-come-non-l-hai-mai-sentita--1762253/support.

Misha Glenny and guests discuss one of the most remarkable scientific discoveries of the 20th century: the archaea microorganisms. In the 1970s the American microbiologist Carl Woese (1928-2012) realised that the tiny bacteria-sized organisms he was studying were not actually bacteria but from an entirely different branch of the tree of life. It became clear that archaea, as he named them, share aspects of the cells in all plants and animals even if they often live in places where other life struggles including salty lakes, acidic pools, under the sea bed and in the gut. While aspects of what followed from Woese are still under debate, further discoveries suggest that life on Earth has been on a journey of separation and reunion: that the first cells developed into bacteria and archaea billions of years ago and that some of those later combined to form the complex cells from which we are made. WithChrista Schleper Professor of Genetics and Microbiology at the University of ViennaThorsten Allers Professor of Archaeal Genetics at the University of NottinghamAndBuzz Baum Group leader at the MRC Laboratory of Molecular Biology in CambridgeProducer: Simon TillotsonReading list: John Archibald, One Plus One Equals One: Symbiosis and the evolution of complex life (Oxford University Press, 2014)Buzz Baum, ‘I': A Biography of the Biological Self (Allen Lane, forthcoming 2027)Franklin M. Harold, In Search of Cell History: The Evolution of Life's Building Blocks (University of Chicago Press, 2014) Nick Lane, Power, Sex, Suicide: Mitochondria and the Meaning of Life (Oxford University Press, 2005)David Quammen, The Tangled Tree: A Radical New History of Life (Simon & Schuster, 2018)Jan Sapp, Evolution by Association: A History of Symbiosis (Oxford University Press, 1994)In Our Time is a BBC Studios ProductionSpanning history, religion, culture, science and philosophy, In Our Time from BBC Radio 4 is essential listening for the intellectually curious. In each episode, host Misha Glenny and expert guests explore the characters, events and discoveries that have shaped our world.

In this Mol Bio Minutes mini-episode of Speaking of Mol Bio, Dr. Andrea Hunger walks listeners through the practical differences between three core PCR approaches: endpoint PCR, quantitative PCR (qPCR), and digital PCR. Drawing on her experience in both academic research and industry, she explains how each technique provides different types of information and why choosing the right one depends on the biological question being asked.  Endpoint PCR is the simplest method and is ideal for basic presence-or-absence questions such as confirming cloning success or genotyping samples. While fast and accessible, it does not provide quantitative information. For experiments requiring measurement of gene expression levels or comparisons between samples, qPCR offers a powerful solution by monitoring amplification in real time and using Ct values and standard curves to estimate starting concentrations. Hunger then discusses digital PCR, a newer technology that partitions samples into many micro-reactions to enable highly precise, absolute quantification of nucleic acids. Because it counts positive and negative partitions directly, digital PCR is especially valuable for detecting rare mutations, low-abundance targets, and applications like liquid biopsy analysis. Ultimately, she emphasizes that these PCR approaches are complementary tools, and the best experimental strategy is to choose the method that provides the level of information required for the next step in a research workflow. Helpful resource links mentioned in this episode:  Access educational eBook covering all three types of PCR and their use in gene expression analysis.  Watch a video on when to choose digital vs. real-time PCR.  Use the PCR primer design tool from Thermo Fisher.  Access Harvard's PrimerBank, a public resource of PCR primers. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Dr Eduardo (Eddy/Eddie) Perez, PhD is the Chief Scientific Officer at Signum Biosciences and a scientific lead behind Epicutis®. He earned his PhD in Biochemistry and Molecular Biology from Rutgers University, with research focused on signal transduction. Dr Perez has more than a decade of experience across biotech and R&D, with expertise spanning dermatology-focused scientific development, evaluation of novel compounds, and formulation science for skin-focused applications. In this episode of Doctor Diaries, live from Melbourne's ASCPD Conference, Dr Eddy Perez joins Hanya Oversby to unpack the science lens behind modern skincare innovation — from how skin barrier biology shapes real-world routines, to why formulation choices matter just as much as headlineingredients. We'll explore how scientific teams assess new compounds, what “skin resilience” means in practical terms, and what clinicians should listen for when separating meaningful innovation from marketing noise. For more information on Dr Perez, click herehttps://www.linkedin.com/in/eduardo-perez-9b5a947/ More information about Hanya Oversby can be found onhttps://hanyaoversby.com.au/ #dreduardoperez #eddieperez #epicutis #signumbiosciences #ascpd.org.au#medicalworld #doctordiariespodcast #hanyaoversby #podcast #medicalbusiness #doctorsofinstagram#aestheticworld #doctor #secretsource #medicalpodcast Doctor Diaries is a podcast series designed for healthcare professionals, featuring in-depth interviews with experienced clinicians across medical aesthetics, dermatology, surgery, and integrative medicine. Each episode provides insights into clinical approaches, practice development, and the realities of patient care in today'sregulatory landscape.This content is intended for qualified healthcare professionals only and may discuss prescription-only products, regulated procedures, and clinical experiences not suitable forgeneral public promotion. Always refer to relevant professional guidelines and product information.

A meningitis outbreak is sparking a massive media fear campaign reminiscent of the early days of the COVID-19 pandemic – but Dr. Jessica Rose warns “don't just get in line like you did last time, please.” The computational biologist and immunologist warns that the public is being driven toward MenB vaccines that carry significant, underreported risks. By analyzing VAERS data and the recombinant technology inside these injections, Dr. Rose exposes the dangers of “molecular mimicry” and explains why injecting synthetic lipoproteins could trigger severe autoimmune responses. Internet pioneer and investigative author Ken McCarthy breaks down the historical and ongoing corruption of the medical industry. Dr. Izabella Wentz, acclaimed author of Hashimoto's Thyroiditis, shares her expertise on combating the rise of medically-induced and environmentally-triggered autoimmune conditions, offering root-cause solutions for mystery illnesses. Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Find her at https://jessicasuniverse.com and follow at https://x.com/JesslovesMJK Ken McCarthy was one of the early pioneers of the movement to commercialize the Internet. Time Magazine credits him with being the first person to articulate the importance of “click-through rate” as a key metric. He's the author of over 10 books, including the bestselling What the Nurses Saw. Learn more at https://BrasscheckBooks.com and https://kenmccarthy.com Dr. Izabella Wentz, PharmD, FASCP is an internationally acclaimed thyroid specialist and licensed pharmacist who has dedicated her career to addressing the root causes of autoimmune thyroid disease, fatigue and mystery illnesses after being diagnosed with Hashimoto's thyroiditis in 2009. She received the PharmD. Degree (Doctor of Pharmacy) from the Midwestern University Chicago College of Pharmacy at the age of 23. Dr. Wentz is the author of the #1 NYT bestseller “Hashimoto's Protocol” and multiple others. Learn more at https://thyroidpharmacist.com 「 SUPPORT OUR SPONSORS 」 • STRONG CELL – If you want to feel more like your younger self, go to https://strongcell.com/ and use code DREW for 20% off. • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/gold⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or text DREW to 35052 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Season 4 premiere of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Nina Pollak from the University of the Sunshine Coast about the development of a single-dose vaccine aimed at protecting endangered koalas from Chlamydia pecorum. The disease is a major threat to koala populations across eastern Australia, contributing to infertility, blindness, and increased mortality. Pollak's work focuses on optimizing the production and quality control of vaccine antigens while supporting regulatory approval and field trials that ultimately led to a conditional minor-use permit from Australia's veterinary regulatory authority.  The vaccine relies on recombinant versions of the major outer membrane protein (MOMP) from three dominant chlamydial genotypes. Using standard molecular biology techniques, including gene cloning in E. coli, His-tag purification, SDS-PAGE verification, western blotting, and mass spectrometry, Pollak's team produces and verifies these vaccine antigens before combining them with adjuvants to stimulate protective immune responses. Beyond the science, the episode explores the challenges of conservation-focused vaccinology: field vaccination of wild animals, limited commercial incentives, and the importance of methods for monitoring disease prevalence. Pollak also reflects on the collaborative nature of the decade-long project and offers advice to young scientists pursuing difficult but meaningful research challenges. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

As more patients present with digestive sensitivity and increasingly restricted diets, restoring gut resilience has become a central clinical challenge. In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald speaks with Colleen Cutcliffe, PhD, CEO and co-founder of Pendulum Therapeutics, about emerging microbiome science and practical strategies for supporting microbial balance, dietary tolerance, and metabolic health. The discussion explores next-generation probiotic strains, fiber diversity, IBS patterns, and real-world approaches clinicians can use to help patients rebuild microbiome resilience and expand diet diversity in practice. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Colleen Cutcliffe, PhD, is CEO and Co-Founder of Pendulum Therapeutics, where she focuses on advancing microbiome science and metabolic health through next-generation probiotic research. She holds a PhD in Biochemistry and Molecular Biology from Johns Hopkins University and brings more than 25 years of experience across biotechnology, pharmaceuticals, and academic research. THANKS TO OUR SPONSOR Pendulum Therapeutics - http://PendulumLife.com/Kara20 Email: hello@pendulumlife.com EXCLUSIVE OFFER FOR NEW FRONTIERS LISTENERS Using next-generation probiotics like live Akkermansia, Pendulum is designed to go beyond gut health to support metabolism. Visit http://PendulumLife.com/Kara20 and use code KARA20 for 20% off your first membership order. CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

In this episode of The Birth Lounge Podcast, HeHe sits down with Kallie Fell, executive director of the Center for Bioethics and Culture, for a thought-provoking conversation about the ethics of surrogacy. Kallie shares why she believes modern surrogacy raises serious concerns about exploitation, commodification, and what she calls “fragmented motherhood,” where the roles of biological, gestational, and social mother are separated. Together, they explore questions about surrogate health risks, potential long-term impacts for children conceived through IVF, and the complicated legal landscape surrounding contracts, autonomy, and representation. Throughout the conversation, HeHe reflects on how her own perspective shifted after becoming pregnant and emphasizes the importance of having open, respectful conversations about topics that are often considered taboo. Guest Bio: From the beginning, Kallie has been passionate about women's health. After graduating with a Masters of Science degree in Animal Sciences with an emphasis on Reproductive Physiology and Molecular Biology and working in the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center,  Kallie continued her education in nursing and has been a perinatal nurse for nearly a decade. Kallie has worked with the CBC since 2018, first as a volunteer writer, then as our staff Research Associate, and now as the Executive Director. In 2021, Kallie co-directed the CBC's first documentary on “transgender medicine” titled Trans Mission: What's the Rush to Reassign Gender? In 2022 Kallie co-wrote and co-produced The Detransition Diaries: Saving Our Sisters. Kallie hosted the popular podcast Venus Rising and is currently the Program Director for the Paul Ramsey Institute. Her latest film, The Lost Boys: Searching for Manhood and new book, co-authored with Jennifer Lahl, The Detransition Diaries (published by Ignatius Press) were both released in early 2024.    About The Center for Bioethics and Culture:  The Center for Bioethics and Culture Network (CBC) is an educational nonprofit addressing bioethical issues that most profoundly affect our humanity, especially issues that arise in the lives of the most vulnerable among us. We work through a variety of media platforms—documentary film, writing, speaking, interviews, social media, and more—to educate and inform members of the general public, thought leaders, lawmakers, and others on ethical issues in healthcare, biomedical research, and biotechnological advancement. We exist to educate and inform members of the general public, thought leaders, lawmakers, and others on ethical issues in healthcare, biomedical research, and biotechnological advancement by intentionally bring together diverse voices from across the spectrum of human experience to build common cause in addressing the crucial questions that accompany these fields.   Connect with CBC: https://cbc-network.org  X: @kal_fell and @CBCnetwork Youtube: https://www.youtube.com/@Cbc-networkOrg  SOCIAL MEDIA: Connect with HeHe on Instagram: https://www.instagram.com/tranquilitybyhehe/  BIRTH EDUCATION: Learn how to stay in control of your birth and reduce the risk of unnecessary interventions in our Avoid a C-Section Webinar. HeHe breaks down the cascade of interventions, explains what's really happening in the hospital, and shares practical strategies to protect your birth plan, advocate for yourself, and navigate labor with confidence. Perfect for anyone who wants a positive, informed hospital birth experience: https://www.thebirthlounge.com/csection Feeling nervous about speaking up in labor? Our Scripts for Advocacy give you the exact words to handle the most common conversations that can make or break your birth experience. From declining unnecessary interventions to asking the right questions about procedures, these scripts empower you to stay in control, speak confidently, and protect your birth plan — even when the pressure is on. Think of it as your personal toolkit for advocating like a pro, so you can focus on your baby, not the stress: https://www.thebirthlounge.com/Scripts-for-Advocacy And if you haven't grabbed it yet… Snag my free Pitocin Guide to understand the risks, benefits, and red flags your provider may not be telling you about, so you can make informed, powerful decisions in labor: https://www.thebirthlounge.com/pitocin Join The Birth Lounge for judgment-free, evidence-based childbirth education from HeHe that shows you exactly how to navigate hospital policies, avoid unnecessary interventions, and have a trauma-free labor experience, all while feeling wildly supported every step of the way: https://www.thebirthlounge.com/ Want prep delivered straight to your phone? Download The Birth Lounge App for bite-sized birth and postpartum tools you can use anytime, anywhere: https://www.thebirthlounge.com/app-download-page LINKS MENTIONED: Just Ingredients Ready to simplify your supplements with a brand you can actually trust? Check out Just Ingredients for clean protein, prenatals, electrolytes, and more, made with real, transparent ingredients. Head to justingredients.us and use code TRANQUILITYBYHEHE to save 10% on your first order.

Welcome to Season 2 of the Orthobullets Podcast.In this episode, we review the high-yield topic of Molecular Biology Basics⁠ ⁠from the Basic Science section.⁠Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube

Are your skincare products "kinda working"… but not really working like they used to? And what if the real issue isn't the ingredients, but your skin cells being too exhausted to respond? Then that would mean we need a different approach. If you're curious about stem cells and exosomes, and how to find them and use them, then this episode is for you. We Cover • What causes skin cells to become "exhausted" and less responsive to skincare ingredients • What exosomes are and how they act as cellular messengers in regenerative medicine • Why peptides may work better when combined with exosomes • The Longevity Serum I am most excited about • How to evaluate exosome skincare products and avoid common red flags Debbi Barber is a skincare innovator and educator focused on longevity-focused aesthetics and regenerative skincare technologies. Dr. Jordan Plews, PhD is a biochemical engineer and stem cell researcher whose work spans regenerative medicine, stem cell biology, and cosmeceutical development. He completed his postdoctoral training at Stanford University after earning degrees in Biochemical Engineering, Bioprocess Development, Stem Cell Research, and Molecular Biology in the UK. Dr. Plews has published research in leading scientific journals. His work has focused on the therapeutic potential of stem cells for injury and degenerative diseases. In 2015 he co-founded Xytogen Biotech, a California-based company developing next-generation stem cell-based skincare solutions. His career bridges biochemical engineering, molecular biology, and regenerative medicine. PAST EPISODE ON COPPER PEPTIDES: https://podcasts.apple.com/us/podcast/the-most-effective-peptide-for-aging-skin-scars-debbi/id1531105768?i=1000701240612 Save 20% on all Vitali Skincare with code ZORA at vitaliskincare.com Contact Debbi Barber: Email: debbi@vitaliskincare.com Website:   https://vitaliskincare.com    Instagram: @vitali_skincare https://www.instagram.com/vitali_skincare/   Contact John Plews: Email: stemcelldoc@gmail.com   Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 20% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

Dr. Carla Finkielstein is an Associate Professor of Biological Sciences within the Biocomplexity Institute of Virginia Tech. She is also Director of the Integrated Cellular Response Laboratory at Virginia Tech, a Member of the Executive Committee of the Susan G. Komen Blue Ridge Board, and past member of the Board of Directors of the Virginia Breast Cancer Foundation. Carla is interested in understanding the mechanisms cells use to measure time to regulate cell division. She hypothesizes that cancer may occur when the clocks within cells signal to the cell to divide too frequently. Carla's goal is to understand how this process occurs so that we can fix the issue, detect the problem early to provide treatment, or prevent it from happening. Outside of science, Carla's favorite hobby is cooking. She loves making new and creative dishes that bring together different colors, flavors, and taste profiles. Cooking is relaxing for her, and it's fun to share dishes she creates with her friends and family. In addition, Carla enjoys reading a wide variety of books about history. Carla received her B.S. and Ph.D. both in Molecular Biology from the University of Buenos Aires in Argentina. Afterwards, she worked as a Research Associate at the Howard Hughes Medical Institute at the University of Colorado Health Sciences Center. Carla then conducted further postdoctoral research at the University of Colorado Health Sciences Center before joining the faculty at Virginia Tech. Carla has been recognized for her research accomplishments with the L. Chely Award for Best PhD Thesis, a Howard Hughes Institute Fellowship for Research, an American Heart Association Postdoctoral Fellowship, the Karin Noss Scholarship for Research Advocacy in Breast Cancer, the Susan G. Komen Award for Junior Investigators, and a National Science Foundation CAREER Award. In our interview Carla shared more about her life and science.

Geneticist Adrian Woolfson shares his insights on designing life with artificial biological intelligence, the possibility of creating new species, and the responsibility that comes with rewriting the rules of evolution. Adrian Woolfson is the co-founder of Genyro, a California-based biotechnology company specialising in synthetic genome design and construction. Born in London, he studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology. He is the author of the critically acclaimed Life Without Genes: The History and Future of Genomes and An Intelligent Person's Guide to Genetics. He has authored over 160 scientific papers, book chapters, reviews, and patents, and is a regular contributor to the Wall Street Journal and Science magazine. Bonus episode recorded live from the World Governments Summit 2026 at the House of Impact on 03 February 2026. Full-Video Version: https://youtu.be/ejHgoD1Wt5I  ABOUT THE HOST Luke Robert Mason is a British-born futures theorist who is passionate about engaging the public with emerging scientific theories and technological developments. He hosts documentaries for Futurism, and has contributed to BBC Radio, BBC One, The Guardian, Discovery Channel, VICE Motherboard and Wired Magazine. CREDITS In Partnership with the Dubai Future Foundation Producer & Host: Luke Robert Mason Join the conversation on Facebook, Instagram, and Twitter at @FUTURESPodcast Follow Luke Robert Mason on Twitter at @LukeRobertMason Subscribe & Support the Podcast at http://futurespodcast.net

Applications are now open for the Marine Institute's 2026 Bursary Programme, which provides third-level students with practical work experience at Ireland's national marine research and development agency. The Marine Institute's Bursary Programme has been operating for over 30 years, providing essential career development and support, and inspiring the next generation of marine scientists and experts. The programme equips third-level students with essential skills and necessary experience to become ocean leaders and marine champions of the future. The Marine Institute is committed to supporting a culture of high performance. This is driven by our people, whose skills, experience and passion for the marine are crucial to our continued delivery of highly impactful services for government and other stakeholders. The Bursary Programme provides undergraduates with a unique opportunity to meet fellow students from other third-level colleges as well as work with experts in their field, helping participants to form future networks in the marine sector. The Bursary Programme is aimed at undergraduate students of Universities and Institutes for Higher Education, both National and International. To participate in the programme, undergraduate students must have completed two years of study in a relevant discipline by the beginning of June 2026. Glenn Nolan, Bursary Programme Lead and Director of Marine Environment and Food Safety Services, said,?"For more than 30 years, the Marine Institute Bursary Programme has enabled undergraduate students to develop their skills and strengthen their knowledge of the marine sector. Participating students emerge equipped to make informed decisions early in their studies about the marine and maritime careers they would like to pursue." Successful candidates will work with full-time Marine Institute staff on critical work programmes, including Marine and Freshwater Fisheries, Oceanography, Machine Learning/AI, Marine Chemistry, Molecular Biology, Marine Spatial Planning, Remote Sensing, Web Development, Socio-economics, and Corporate Services. The bursaries are based at Marine Institute facilities in Oranmore, Co. Galway, and Newport, Co. Mayo. To apply for the Marine Institute's 2026 Bursary Programme: View the bursary titles available. Select the two bursary positions that interest you the most, in order of preference. Complete the onlineapplication formandsubmitas per the instructions:?https://forms.office.com/ Application Deadline Date is 16:00, Friday, 27th?February 2026. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

This episode was originally released on December 13, 2022Stop the presses! New research shows that viruses locked in the Arctic permafrost for thousands of years have the potential to infect present-day organisms. Accompanied with a warming planet, this issue is really starting to thaw out. So what can brave scientists and institutions on the frontlines of tracking diseases do about it? And how can understanding our genomic history with diseases over thousands of years better prepare us in the fight to overcome them?Dr. Kaylee Byers starts our journey by slinking into a disease-tracking genomics lab at Simon Fraser University to meet Dr. Michael Trimble and Dr. Will Hsiao to understand the challenge of outpacing the rapid evolution of viruses. Then she pops across the ocean to speak with Dr. Birgitta Evengård and Dr. Jean-Michel Claverie about whether the Pandora's box of ancient diseases frozen in the arctic have the potential to become the next global outbreak as temperatures warm. Plus, we unearth ancient burial sites in Vietnam with Dr. Melandri Vlok, to investigate how climate change exacerbates the tension between human health and pathogens.Special thanks to Dr. Will Hsiao and Dr. Michael Trimble for allowing us to record with them at Simon Fraser University.Resources:1. Infection control in the new age of genomic epidemiology | British Columbia Centre for Disease Control Public Health Laboratory2. The permafrost pandemic: could the melting Arctic release a deadly disease | Unearthed3. Viral spillover risk increases with climate change in High Arctic lake sediments | The Royal Society4. Healthy ecosystems for human and animal health: Science diplomacy for responsible development in the Arctic | The Nordic Centre of Excellence5. Understanding and Responding to Global Health Security Risks from Microbial Threats in the Arctic: Proceedings of a Workshop | National Academies of Science, Engineering, Medicine6. Next pandemic may come from melting glaciers, new data shows | The Guardian7. Scientists Revived Ancient 'Zombie Viruses' Frozen For Eons in Siberia | Science Alert8. A 48,500-year-old virus has been revived from Siberian permafrost | NewScientist9. Anthrax outbreak in Siberia | euro news10. CBC News: The National | Russia invades Ukraine | Canadian Broadcast Corporation (CBC)11. National Geographic: Explorer Directory, Melandri Vlok | National Geographic12. Paleoepidemiological Considerations of Mobility and Population Interaction in the Spread of Infectious Diseases in the Prehistoric Past | Bioarchaeology International13. The Epidemiological Transition: A Theory of the Epidemiology of Population Change | Milbank Memorial Fund14. Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia | nature portfolio15. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database | Department of Molecular Biology and Biochemistry, Simon Fraser University

How do you build an organization that can absorb change, learn from failure, and keep patients at the center—even when the science is uncertain? Nelly Viseux shares lessons from over 20 years in biotech and a decade leading cell and gene therapy development.Nelly discusses how she structured a 100-person CMC organization at Regeneron to balance innovation with operational execution, why documenting your assumptions is critical to managing risk, and what it really takes to maintain resilience when you're literally holding patient lives in your hands.A few of Nelly's key takeaways:Resilience is adaptability—build organizations that absorb and anticipate change rather than resist itSeparate innovation from execution with intentional gates for when new approaches are ready to implementDocument your assumptions so you can revisit decisions effectively when circumstances changeFailure is a process problem, not a personal one—root cause analysis should improve systems, not assign blameData is the common language that aligns scientists, regulators, and stakeholdersEveryone is a leader in cell therapy—manufacturing and QC teams hold patient lives in their handsAbout Nelly ViseuxNelly Viseux is Vice President of Cell Therapies Development, Manufacturing, Supply & Quality at Regeneron, leading a 100-person organization supporting autologous cell therapy programs. She has over 20 years of biotechnology experience spanning large pharma (Shire, Biogen, Baxter) and startups, working across cell and gene therapies, biologics, and nanoparticles. Her accomplishments include building a Phase 1 cell therapy manufacturing facility that achieved 100% cGMP success and first IND submission within two years. She holds a Ph.D. in Biochemistry and Molecular Biology from University of Lille and is a member of the Society for Immunotherapy of Cancer and the American Society of Gene & Cell Therapy.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle—from clinical development to commercialization—with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations. Learn more: ⁠⁠https://www.thefdagroup.com/

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

******Support the channel******Patreon: https://www.patreon.com/thedissenterPayPal: paypal.me/thedissenterPayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuyPayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9lPayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpzPayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9mPayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao ******Follow me on******Website: https://www.thedissenter.net/The Dissenter Goodreads list: https://shorturl.at/7BMoBFacebook: https://www.facebook.com/thedissenteryt/Twitter: https://x.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. Coleen Murphy is James A. Elkins Jr. Professor in the Life Sciences, and Professor of Molecular Biology and Director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University. She is the author of How We Age: The Science of Longevity. In this episode, we focus on How We Age. We discuss the science of aging, what we can learn from it, why we age, and what we can learn from animal models and centenarians. We also talk about longevity pathways, and transgenerational effects. We discuss whether intermittent fasting works. We talk about the role of DNA repair and cell replacement. We discuss whether the gut microbiome plays a role in aging. Finally, we talk about the current state of longevity biotech, and how to approach new developments.--A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, BERNARDO SEIXAS, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, YANICK PUNTER, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, HEDIN BRØNNER, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, WILLIAM BUCKNER, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ALEX CHAU, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, JEFF MCMAHAN, JAKE ZUEHL, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, JESSICA NOWICKI, LINDA BRANDIN, VALENTIN STEINMANN, ALEXANDER HUBBARD, BR, JONAS HERTNER, URSULA GOODENOUGH, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, LUCY, MANVIR SINGH, PETRA WEIMANN, CAROLA FEEST, MAURO JÚNIOR, 航 豊川, TONY BARRETT, NIKOLAI VISHNEVSKY, STEVEN GANGESTAD, TED FARRIS, HUGO B., JAMES, JORDAN MANSFIELD, CHARLOTTE ALLEN, PETER STOYKO, DAVID TONNER, LEE BECK, PATRICK DALTON-HOLMES, NICK KRASNEY, RACHEL ZAK, DENNIS XAVIER, CHINMAYA BHAT, AND RHYS!A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, NICK GOLDEN, CHRISTINE GLASS, IGOR NIKIFOROVSKI, AND PER KRAULIS!AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER,SERGIU CODREANU, AND GREGORY HASTINGS!

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

Dr. Jessica Rose, PhD, MSc, BSc, is a Senior Fellow specializing in Computational Biology from Canada. She holds a Bachelor's Degree in applied mathematics and a master's degree in Immunology from Memorial University of Newfoundland, and a PhD in Computational Biology from Bar Ilan University. Dr. Rose has completed two post-doctoral degrees in Molecular Biology from the Hebrew University of Jerusalem, and in Biochemistry from the Technion Institute of Technology. She is best known for her contributions to public health and safety related to the COVID-19 injectable products, and her analyses of pharmacovigilance databases like VAERS. In this episode, Drs. Brian and Jessica talk about… (00:00) Intro (04:57) Dr. Jessica's upbringing, personality, and scientific pursuits (09:41) Covid vaccines, natural immunity, and bodily autonomy of individuals (19:50) The research of Kevin McKernan on DNA in vials of COVID-19 vaccines (27:39) The composition and production of Covid mRNA vaccines (33:04) National health regulation agencies and Covid vaccine DNA contamination (35:54) Lipid nanoparticles in mRNA vaccines and how they impact human health (44:22) Vaccine injuries due to spike protein proliferation and how the spike protein ruins the human immune system (54:38) Spike protein detox therapies (01:01:12) Fascia release (01:03:07) Cholesterol, gal bladder health, and nutrition (01:07:54) Fasting, autophogy, and the microbiome (01:11:33) Peer review and post-peer review attacks on valid research (01:21:53) Outro   For more information, please see the links below. Thank you for listening!   Links:   Resources Mentioned in this Episode: Jules Horn (Fascia Release): https://www.youtube.com/@Jules_horn Science Guardians (post-peer review group): https://x.com/SciGuardians   Dr. Jessica Rose: Research: https://www.researchgate.net/profile/Jessica-Rose-24 Why does DNA remain in vials of COVID-19 mRNA Shots?: https://rumble.com/v74rdvs-why-does-dna-remain-in-vials-of-covid-19-mrna-shots.html What Jessica Rose Knows: Dr. Jessica Rose on DarkHorse: https://rumble.com/v5q0zl8-what-jessica-rose-knows-dr.-jessica-rose-on-darkhorse.html   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

In this episode of Ordinarily Extraordinary: Conversations with Women in STEM, host Kathy Nelson sits down with Dr. Elizabeth Mendes, a newly minted PhD and postdoctoral researcher whose work focuses on rare and aggressive pediatric cancers.Dr. Mendes recently completed her PhD at Duke University, where she spent over five years researching rhabdomyosarcoma, a rare childhood soft-tissue cancer. Her goal: identify new biological targets that could one day lead to better, more effective treatments for children. Kathy and Liz explore not only the science behind pediatric cancer research, but also the deeply human reasons that drive this work.What We Talk About in This EpisodeWhat pediatric sarcomas are—and why they're so challenging to treatLiz breaks down complex cancer biology in an approachable way, explaining how sarcomas differ from more common cancers and why their ability to “change form” makes them particularly dangerous.A non-traditional path into scienceFrom archaeology and zoology to teaching middle school math and science, Liz shares how curiosity—and not a straight line—ultimately led her to molecular biology, cancer research, and a PhD.Choosing pediatric cancer researchLiz explains why she decided to focus on rare childhood cancers that receive less funding but have devastating outcomes—and how personal experiences with cancer shaped that decision.Science close to the patientWe discuss the importance (and rarity) of researchers interacting directly with patients, families, and clinicians—and how those experiences fundamentally change how science is done.Life after the PhD: postdocs, fellowships, and moving to the UKLiz shares what it's like to finish a PhD, move countries, start a new research position, and navigate life and work during a major transition.Being your whole self in STEMFrom makeup and music to mental health and social media, Liz talks about rejecting outdated stereotypes of what scientists “should” look like—and why authenticity matters for the next generation.Representation, mentorship, and science communicationLiz reflects on why visibility matters, especially for women and first-generation students, and how platforms like social media can help make science more accessible and human.A Conversation About More Than ScienceThis episode goes beyond lab work and credentials. It's a candid conversation about grief, resilience, identity, and the responsibility scientists carry—not just to discovery, but to people. Liz's story is a powerful reminder that STEM careers don't require fitting into a mold—and that compassion belongs in science.If you enjoyed this episode:Rate and review the podcast on Apple Podcasts or SpotifyFollow or subscribe so you never miss an episodeShare with a friend, colleague, or student who might need this storyHave thoughts, questions, or guest suggestions?Email us at ordinarilyextraordinarypod@gmail.com or leave a voicemail on our website.Support the show

THE RIPPLE EFFECT PODCAST:Website: http://TheRippleEffectPodcast.comSupport: https://rickyvarandas.com/support/IPAK-EDU (Empower Yourself Through Knowledge)Website: https://IPAK-EDU.org/ (use RIPPLE for 10% off)VN Alexander, PhD (aka Tori)Website: https://vnalexander.com/IG: https://www.instagram.com/rednaxelairot/AI & Transhumanism Essay: posthumousstyle.substack.comBio: Philosopher of science known for her work on Vladimir Nabokov's theory of insect mimicry evolution. She is a member of the Third Way of Evolution research group and currently works in the field of Biosemiotics.  She earned her Ph.D. in 2002 in English at the Graduate Center, City University New York and did her dissertation research in teleology, evolutionary theory, and self-organization at the Santa Fe Institute. She is a Rockefeller Foundation Residency alum, a former NY Council for the Humanities scholar, and a 2020 Fulbright scholar in Russia. Books include The Biologist's Mistress: Rethinking Self-Organization in Art, Literature and Nature and several literary fiction and political science novels.Xavier A. Figueroa, Ph.D (aka Dr. X)X: https://x.com/DrXFig0708Bio: The principal scientist for EMulate Therapeutics overseeing pre-clinical research and the application of EMulate Therapeutics technology in multiple disease areas. He has more than 20 years of experience in basic and neurological clinical research, including Alzheimer's research, neuron biology, cancer research, bioengineering and biophysics. Dr. Figeuroa received his doctoral degree in Neurobiology & Behavior from the University of Washington. His doctoral training was followed by two post-doctoral fellowships within the University of Washington's Department of Bioengineering. He is currently an affiliate assistant professor in the School of Medicine at the University of Washington. Specialties include, Molecular Biology, Toxicology, Apoptosis Signaling and Regulation, Neuroscience and Neurodegenerative Expertise.Dr. James Lyons-Weiler (aka Dr. Jack)Website: https://jameslyonsweiler.com/Substack: https://popularrationalism.substack.com/Earned his PhD in Ecology, Evolution, and Conservation Biology. He has held research positions at esteemed institutions, including the University of Nevada, Reno, and the University of Pittsburgh (Dept Pathology & Dept. of Biomedical Informatics). Dr. Lyons-Weiler has an extensive portfolio of peer-reviewed articles covering various scientific disciplines such as genetics, evolution, and public health. Notably, he has conducted research on the safety of aluminum adjuvants in vaccines, focusing on their dosing and potential health implications, especially in pediatric populations. His work on “pathogenic priming” and its potential relevance to COVID-19 has also been significant. Lyons-Weiler founded the Institute for Pure and Applied Knowledge (IPAK), a research organization. He also founded IPAK-EDU, an educational platform that has educated over 1,400 students in advanced courses across a wide variety of subjects. You can find more information about these courses on their official website.

We're back and better than ever. Season 4 of Absolute Gene-ius is officially here, and this teaser gives you a front-row seat to what's coming. From scientific puns to sneak peeks of the upcoming guest lineup, co-hosts Jordan Ruggieri and new addition Lisa Crawford set the tone for another season of engaging, educational, and entertaining molecular biology content.This season, the show expands its scope beyond digital PCR to include real-time PCR and other tools that are working together to move research forward in fields like oncology, agriculture, behavioral psychiatry, and more. Lisa brings a non-scientist's view to the show along with a deep passion for translating complex science into compelling stories. Whether it's microvesicles, stem cells, or high-containment biosafety labs, the upcoming episodes promise to be both technically informative and very human.And in classic Absolute Gene-ius fashion, we keep it fun. From how guests got into science, to what thy love most about it, and lab fail stories, the Career Corner returns with fresh energy and laughs. Expect bad puns, big discoveries, and the beautiful chaos of real-world research. Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.

Does water on a hen make it more susceptible to predation? In this episode, we comb through the literature on olfactory camouflage, dissecting studies assessing correlations between nest survival, weather, and environmental conditions, and divulging into the complicated web of ecology dynamics. Strap on your science boots for this one, it's gonna be dense… Research papers referenced: Bakner, N. W., et al.  (2019). Incubation recess behaviors influence nest survival of Wild Turkeys. Ecology and Evolution, 9(24), 14053-14065. Boone, W. W., et al. (2024). Robust assessment of associations between weather and eastern wild turkey nest success. The Journal of Wildlife Management, 88(2), e22524. Braun, M. S., et al. (2018). Birds, feather-degrading bacteria and preen glands: the antimicrobial activity of preen gland secretions from turkeys (Meleagris gallopavo) is amplified by keratinase. FEMS microbiology ecology, 94(9), fiy117. Conover, M. R. (2007). Predator-prey dynamics: the role of olfaction. CRC Press. Fluen, T. (2008). A comparative analysis of evolutionary changes in island birds. MSc Thesis, University of Canterbury, Christchurch. Grieves, L. A., et al. (2020). Food stress, but not experimental exposure to mercury, affects songbird preen oil composition. Ecotoxicology, 29, 275-285. Grieves, L. A., et al. (2022). Olfactory camouflage and communication in birds. Biological Reviews, 97(3), 1193-1209. Lehman, C. P., et al. (2010). Ground roost resource selection for Merriam's wild turkeys. The Journal of Wildlife Management, 74(2), 295-299. Lowrey, D. K., et al. (2001). Influences of selected weather variables on predation of wild turkey females and nest success. In Proceedings of the National Wild Turkey Symposium (Vol. 8, pp. 173-178). Potier, S., et al. (2018). Preen oil chemical composition encodes individuality, seasonal variation and kinship in black kites Milvus migrans. Journal of Avian Biology, 49(7), e01728. Reneerkens, J., et al. (2002). Sandpipers (Scolopacidae) switch from monoester to diester preen waxes during courtship and incubation, but why?. Proceedings of the Royal Society of London. Series B: Biological Sciences, 269(1505), 2135-2139. Reneerkens, J., et al. (2005). Switch to diester preen waxes may reduce avian nest predation by mammalian predators using olfactory cues. Journal of Experimental Biology, 208(22), 4199-4202. Reneerkens, J., et al. (2006). Discerning adaptive value of seasonal variation in preen waxes: comparative and experimental approaches. Acta Zoologica Sinica, 52, 272-275. Reneerkens, J., et al. (2007a). Parental role division predicts avian preen wax cycles. Ibis, 149(4), 721-729. Tuttle, E. M.,et al. (2014). Variation in preen oil composition pertaining to season,sex, and genotype in the polymorphic white-throated sparrow.Journal of ChemicalEcology40, 1025–1038. Whelan, R. J., et al. (2010). Short-chain carboxylic acids from gray catbird (Dumetella carolinensis) uropygial secretions vary with testosterone levels and photoperiod. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 156(3), 183-188. Webb, S. L., et al. (2012). Landscape features and weather influence nest survival of a ground-nesting bird of conservation concern, the greater sage-grouse, in human-altered environments. Ecological Processes, 1, 1-15. Episodes referenced: Effectiveness of trapping across game bird species | #08 Which vital rates are most important to turkey populations? | #13 Brooding and nesting cover (Part 1/2) | #29 Brooding and nesting cover (Part 2/2) | #30   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Coming Soon: Wild Turkey Manager: Biology, History, & Heritage! Our newest online wild turkey training is launching soon! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak

Does water on a hen make it more susceptible to predation? In this episode, we comb through the literature on olfactory camouflage, dissecting studies assessing correlations between nest survival, weather, and environmental conditions, and divulging into the complicated web of ecology dynamics. Strap on your science boots for this one, it's gonna be dense… Research papers referenced: Bakner, N. W., et al.  (2019). Incubation recess behaviors influence nest survival of Wild Turkeys. Ecology and Evolution, 9(24), 14053-14065. Boone, W. W., et al. (2024). Robust assessment of associations between weather and eastern wild turkey nest success. The Journal of Wildlife Management, 88(2), e22524. Braun, M. S., et al. (2018). Birds, feather-degrading bacteria and preen glands: the antimicrobial activity of preen gland secretions from turkeys (Meleagris gallopavo) is amplified by keratinase. FEMS microbiology ecology, 94(9), fiy117. Conover, M. R. (2007). Predator-prey dynamics: the role of olfaction. CRC Press. Fluen, T. (2008). A comparative analysis of evolutionary changes in island birds. MSc Thesis, University of Canterbury, Christchurch. Grieves, L. A., et al. (2020). Food stress, but not experimental exposure to mercury, affects songbird preen oil composition. Ecotoxicology, 29, 275-285. Grieves, L. A., et al. (2022). Olfactory camouflage and communication in birds. Biological Reviews, 97(3), 1193-1209. Lehman, C. P., et al. (2010). Ground roost resource selection for Merriam's wild turkeys. The Journal of Wildlife Management, 74(2), 295-299. Lowrey, D. K., et al. (2001). Influences of selected weather variables on predation of wild turkey females and nest success. In Proceedings of the National Wild Turkey Symposium (Vol. 8, pp. 173-178). Potier, S., et al. (2018). Preen oil chemical composition encodes individuality, seasonal variation and kinship in black kites Milvus migrans. Journal of Avian Biology, 49(7), e01728. Reneerkens, J., et al. (2002). Sandpipers (Scolopacidae) switch from monoester to diester preen waxes during courtship and incubation, but why?. Proceedings of the Royal Society of London. Series B: Biological Sciences, 269(1505), 2135-2139. Reneerkens, J., et al. (2005). Switch to diester preen waxes may reduce avian nest predation by mammalian predators using olfactory cues. Journal of Experimental Biology, 208(22), 4199-4202. Reneerkens, J., et al. (2006). Discerning adaptive value of seasonal variation in preen waxes: comparative and experimental approaches. Acta Zoologica Sinica, 52, 272-275. Reneerkens, J., et al. (2007a). Parental role division predicts avian preen wax cycles. Ibis, 149(4), 721-729. Tuttle, E. M.,et al. (2014). Variation in preen oil composition pertaining to season,sex, and genotype in the polymorphic white-throated sparrow.Journal of ChemicalEcology40, 1025–1038. Whelan, R. J., et al. (2010). Short-chain carboxylic acids from gray catbird (Dumetella carolinensis) uropygial secretions vary with testosterone levels and photoperiod. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 156(3), 183-188. Webb, S. L., et al. (2012). Landscape features and weather influence nest survival of a ground-nesting bird of conservation concern, the greater sage-grouse, in human-altered environments. Ecological Processes, 1, 1-15. Episodes referenced: Effectiveness of trapping across game bird species | #08 Which vital rates are most important to turkey populations? | #13 Brooding and nesting cover (Part 1/2) | #29 Brooding and nesting cover (Part 2/2) | #30   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Coming Soon: Wild Turkey Manager: Biology, History, & Heritage! Our newest online wild turkey training is launching soon! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak

Send us a textWhat if cancer didn't have to be eradicated, but could be remembered, monitored, and controlled by the immune system itself?In this episode of Causes or Cures, Dr. Eeks speaks with Dr. Zachary Hartman, the lead researcher who revisited an extraordinary breast cancer vaccine trial conducted over 20 years ago. The trial involved a small group of women with advanced breast cancer. Women who, remarkably, are all still alive today.By analyzing their blood decades later, the research team discovered that these women still carried immune cells capable of recognizing their cancer, suggesting durable immune memory lasting more than two decades. (Study link here.)We discuss:The original breast cancer vaccine trial and what it was designed to do, in plain languageWhat it was like to discover that the women from the trial was still alive more than 20 years laterHow the immune systems of these women continued to recognize cancer cells long after the trialWhat CD27-positive immune cells are and why they matter, explained simplyWhy helper CD4 T cells may be just as important, or more important, than killer CD8 T cells when it comes to cancerWhat happened when researchers combined a CD27-boosting antibody with a cancer vaccine in miceWhat surprised the research team mostThe challenges of translating findings from mice to human trialsWhether cancer could someday be managed long-term by the immune systemHow generalizable this immune memory might be across different cancersWhat this research could mean for how we think about vaccines in a post-pandemic worldThe one key message the researcher hopes the public takes awayWhat's next in this line of researchThis episode offers a rare, hopeful (but scientifically grounded) look at how the immune system may be capable of remembering cancer for decades. Guest Bio: Dr. Zachary C. Hartman is an Associate Professor at Duke University in the Departments of Surgery, Pathology, and Integrative Immunobiology, where he also serves as Director of the Center for Applied Therapeutics and is a member of the Cellular and Molecular Biology and Genetics and Genomics programs. He earned his undergraduate degree from Northwestern University and completed his PhD at Duke University, followed by postdoctoral training in tumor immunology and breast oncology at Duke and the MD Anderson Cancer Center. In 2012, Dr. Hartman returned to Duke to establish a research program focused on tumor immunology and the development of cancer immunotherapies, including therapeutic vaccines, immune agonists, checkpoint inhibitors, antibody-based therapies, and strategies to stimulate anti-tumor immune responses.  Work with me? Perhaps we are a good match. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Follow Public Health is WeirdOr Facebook here.Or X.OnSupport the show

What do you think of thiamine as a treatment for Parkinson's?Is there a natural thyroid medicine you recommend that is not pork-derived?Please discuss the COVID-19 vaccine and cardiology issuesCan you help my granddaughter with guttate psoriasis?

Holiday Stress tops tax season stressWhat would Dr. Hoffman say?Is berberine truly efficacious?My doctor recommends I drink alcohol to reduce stress and improve circulation

In this episode, Dr. Jun Ding joins us to explore how artificial intelligence and machine learning are reshaping biomedical research at the cellular level. Dr. Ding is an Assistant Professor in the Division of Respiratory Medicine at the Research Institute of the McGill University Health Centre and leads the Ding Lab at McGill University's Meakins-Christie Laboratories. Dr. Ding's research focuses on decoding cell dynamics across complex diseases by leveraging advanced single-cell technologies and computational biology. By developing machine-learning models such as probabilistic graphical models, Dr. Ding and his team aim to bridge massive omics datasets with actionable biological insight – paving the way for next-generation diagnostics and therapeutics… Hit play to discover: Why understanding cell dynamics is critical to tackling complex diseases like cancer. How single-cell and spatial omics technologies are revealing previously hidden biological heterogeneity. The role of machine learning in modeling disease progression and identifying new drug targets. To learn more about Dr. Ding and his work, visit The Ding Lab website!

Vitamin B12 is essential for energy production, nervous system function, and overall metabolic health, but not all B12 forms deliver equal bioavailability or stability. In Episode #196 of the PricePlow Podcast, we welcome back HTBA (HealthTech BioActives) for a comprehensive deep dive into the science behind their MecobalActive methylcobalamin ingredient and the groundbreaking clinical study that validates its efficacy in athletes who are not deficient. Joining us are Teresa Pellicer, PhD, Pharmacologist and R&D Manager in Biotechnology at HTBA, and Bernardo Gonzaga, Global Division Manager for Functional Health Solutions. This conversation builds on Episode #188 with Edwin Gonzalez, where we explored practical applications of MecobalActive in functional foods. Today, we go deeper into the molecular mechanisms, clinical evidence, bioavailability data, and manufacturing innovations that make MecobalActive a next-generation B12 solution for supplements, functional foods, and beverages. Teresa’s expertise in pharmacology and molecular biology shines as she explains why methylcobalamin represents the biologically active form your body actually uses, while Bernardo provides industry context on applications, regulatory considerations, and market opportunities. Subscribe to the PricePlow Podcast on your favorite platform, and sign up for HTBA news alerts before we dive into the science. https://blog.priceplow.com/podcast/podcast/htba-mecobalactive-vitamin-b12-196 Video: The Science Behind MecobalActive Vitamin B12 https://www.youtube.com/watch?v=3v5NgW5jD-E Detailed Show Notes: Teresa Pellicer and Bernardo Gonzaga Discuss MecobalActive B12 (0:00) – Welcome and Introductions (2:00) – Teresa’s Background in Pharmacology and Molecular Biology (4:15) – Bernardo’s Industry Journey and Global Perspective (6:30) – HTBA Company History and Four Business Divisions (9:15) – Pharmaceutical-Grade Quality for Injectable B12 (11:00) – Sustainability Story: Upcycling Baby Oranges for Bioflavonoids (13:45) – ESG Commitment Beyond Environmental Impact (16:00) – Why Vitamin B12 Matters for Energy and Health (19:30) – The Four Main Forms of Vitamin B12 (22:45) – Why Cyanocobalamin Dominates Despite Conversion Requirements (26:15) – MecobalActive: Solving Methylcobalamin’s Stability Challenge (29:45) – The Clinical Study Design and Objectives (33:00) – Study Results: Superior Bioavailability and Faster Absorption (36:30) – Methylation Pathways and Homocysteine Metabolism (40:00) – Adenosylcobalamin and Mitochondrial Energy Production (43:45) – Populations at Risk for B12 Deficiency (47:15) – Symptoms and Consequences of B12 Deficiency (51:00) – Absorption Mechanisms: Intrinsic Factor Pathway (54:45) – Passive Diffusion and High-Dose Supplementation (58:15) – Manufacturing Challenges with Methylcobalamin Stability (1:01:30) – Applications in Functional Foods and Beverages (1:05:00) – Dosing Considerations and Safety Profile (1:08:30) – Combining B12 with Other B Vitamins and Nutrients (1:12:00) – Regulatory Landscape Across Global Markets (1:15:45) –… Read more on the PricePlow Blog

In this episode, we are joined by Dr. Kristy McAndrew from Mississippi State University. Dr. McAndrew will walk us through the ins and outs of Brown spot needle blight, a fungal disease that infects pine needles, leading to premature needle loss, stunted growth, and long-term stress that increases a tree's vulnerability to other pests and pathogens, and provide an update on Emerald Ash Borer presence in the region.  Dr. McAndrew is a forest health specialist at Mississippi State University in the Forestry Department. Kristy has a Bachelor of Science in Forestry and a Bachelor of Science in Fisheries & Wildlife, both from the University of Missouri in Columbia, MO, and also completed a Master's and PhD at Mississippi State University in the Department of Biochemistry, Molecular Biology, Entomology, and Plant Pathology.  For more on brown spot needle blight, see this recent article and publication from the Arkansas Division of Agriculture. www.uaex.uada.edu/media-resources/news/2025/august/08-18-2025-ark-UAM-needle-blight.aspx If you have questions, feel free to contact us at timberuniversity@gmail.com

Today Jeremy is joined by Susan Morrow, PhD, who obtained her Doctor of Philosophy in Molecular Biology and Biochemistry from Louisiana State University Health Sciences Center.  Susan describes her unique childhood growing up in a funeral parlor, her educational journey as well as moral conflicts she experienced as a professional scientist, and her ultimate decision to devote herself full time to raising her family.

Send us a textIn this episode of Unwritten Beauty Talks, host Katarina Forster sits down with Dr. Dave Stachura and Tiffany Underwood from Factor Five Skincare to explore the science behind growth factors, stem cells, exosomes, and clean beauty.They discuss Factor Five's mission to create effective, clean skincare products without fillers or unnecessary additives, the science behind their formulations, and how their products address a wide range of skin concerns. The conversation also delves into how skincare treatments promote healing, collagen production, and client confidence, while highlighting the differences between stem cells, growth factors, and exosomes.Factor Five Skincare focuses on growth factors and stem cells to deliver effective skincare solutions.Their mission is to provide clean, additive-free products without compromising results.Understanding the differences between stem cells, growth factors, and exosomes is key for informed skincare decisions.Skincare treatments often involve controlled disruptions to promote healing, collagen production, and skin renewal.Factor Five products are designed for a wide range of skin types and concerns, including sensitive skin.Their eye and lash cream is highly effective and safe for daily use.Retinol can be safely included in skincare for sensitive skin when formulated correctly.Exosomes need to be stabilized for effective use in topical skincare products.Dr. Dave Stachura – Chief Operations Officer and Chief Scientific Officer at Factor Five Skincare and SpecBio, Dr. Stachura leads the science behind all Factor Five formulations. He holds a BSc in Molecular Biology from Lehigh University and a PhD in Cellular and Molecular Biology from the University of Pennsylvania, followed by postdoctoral training at UC San Diego. His career focuses on genetic control of adult stem cell biology using hematopoietic stem cells (HSCs) and adipose-derived mesenchymal stem cells (ADMSCs). Dr. Stachura has several patents, published over 40 peer-reviewed articles, contributed two book chapters, and edited an immunology textbook. He continues research in stem cells, immunology, exosomes, skincare, and wound healing and founded Philanthropic Pharma, a nonprofit pharmaceutical company aimed at discovering new treatments for human diseases.Tiffany Underwood – Director of Education at Factor Five Skincare, Tiffany works closely with professional partners and brings a strong clinical perspective to the team. A licensed esthetician and founder of SkinCo, she blends biology, product formulation, and advanced esthetics to deliver results-driven treatments while empowering professionals to stay connected to their “why.” Inspired by her journey with cancer.

Looking for more information on this topic? Check out the Shock brick. If you enjoyed this episode, we'd love for you to leave a review on Apple Podcasts.  It helps with our visibility, and the more med students (or future med students) listen to the podcast, the more we can provide to the future physicians of the world. Follow USMLE-Rx at: Facebook: www.facebook.com/usmlerx Blog: www.firstaidteam.com Twitter: https://twitter.com/firstaidteam Instagram: https://www.instagram.com/firstaidteam/ YouTube: www.youtube.com/USMLERX Learn how you can access over 150 of our bricks for FREE: https://usmlerx.wpengine.com/free-bricks/ from our Musculoskeletal, Skin, and Connective Tissue collection, which is available for free. Learn more about Rx Bricks by signing up for a free USMLE-Rx account: www.usmle-rx.com You will get 5 days of full access to our Rx360+ program, including nearly 800 Rx Bricks.  After the 5-day period, you will still be able to access over 150 free bricks, including the entire collections for General Microbiology and Cellular and Molecular Biology.

mRNA vaccines are not supposed to contain DNA. But Dr. Jessica Rose says a new study tested “32 vials of Pfizer and Moderna COVID products that included 16 unique lots… We did not only find DNA, we found it in ALL lots tested and most importantly, the DNA levels were all above pre-designated EMA thresholds of 10 ng/dose.” “We measured the amount of DNA in the vials using 2 methods… (qPCR and fluorometry),” she continues. “It was submitted as evidence on the congressional record by the honorable Senator Ron Johnson.” JP Sears is a comedian, author, and YouTuber known for his satirical take on politics, fitness, and faith. He hosts Awaken with JP on Rumble and YouTube. Follow at https://x.com/AwakenWithJP Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Find her at https://jessicasuniverse.com and follow at https://x.com/JesslovesMJK 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at https://drdrew.com/vshredmd • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) and Susan Pinsky (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/firstladyoflov⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠e⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices